FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/062765 [Registered on: 16/02/2024] Trial Registered Prospectively
Last Modified On: 09/02/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of Exercise on Age related muscle weakness among People with Type 2 diabetes mellitus  
Scientific Title of Study   Effect of Exercise-based Intervention on Mitochondrial Dysfunction in Type 2 Diabetes Mellitus with Sarcopenia- A Randomized Controlled Trial  
Trial Acronym  Nil  
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Deeksha Shettigar  
Designation  PhD Scholar  
Affiliation  Manipal College of Health Professions, Manipal Academy of Higher Education  
Address  Center for Podiatry and Diabetic Foot Care and Research Department of Physiotherapy Manipal College of Health Professions Manipal Academy of Higher Education Manipal Karnataka

Udupi
KARNATAKA
576104
India 
Phone  9620886655  
Fax    
Email  dee.shettigar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Deeksha Shettigar  
Designation  PhD Scholar  
Affiliation  Manipal College of Health Professions, Manipal Academy of Higher Education  
Address  Center for Podiatry and Diabetic Foot Care and Research Department of Physiotherapy Manipal College of Health Professions Manipal Academy of Higher Education Manipal Karnataka

Udupi
KARNATAKA
576104
India 
Phone  9620886655  
Fax    
Email  dee.shettigar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr G Arun Maiya  
Designation  Chief Center for Podiatry and Diabetic Foot Care and Research Dean MCHP Professor  
Affiliation  Manipal College of Health Professions, Manipal Academy of Higher Education Manipal  
Address  Center for Podiatry and Diabetic Foot Care and Research Department of Physiotherapy Manipal College of Health Professions Manipal Academy of Higher Education Manipal Karnataka

Udupi
KARNATAKA
576104
India 
Phone  9845350823  
Fax    
Email  ajmaiya@gmail.com  
 
Source of Monetary or Material Support  
ICMR Extramural Research Programme Investigator Initiated Projects Intermediate grant Dr Pulkit Verma Scientist C Division of BMI ICMR Headquarters New Delhi 110029  
 
Primary Sponsor  
Name  ICMR Extramural Research Programme Investigator Initiated Projects Intermediate Grant  
Address  Dr Pulkit Verma Scientist C Division of BMI ICMR Headquarters New Delhi 110029 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
Nil    
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Deeksha Shettigar  Kasturba Hospital Manipal   Kasturba Hospital Room No. 4 Center for Podiatry and Diabetic Foot Care and Research Department of Physiotherapy First Floor N Block Manipal Karnataka 576104
Udupi
KARNATAKA 
9620886655

dee.shettigar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E116||Type 2 diabetes mellitus with other specified complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Exercise-based Intervention   Exercise-based intervention will be administered for 12 weeks which will mainly target on muscle strength, muscle mass and improving quality of life. It consists of Resistance training, Aerobic exercise and Balance exercise. Exercises will be progressed as per the resistance, and repetition in the 4th and 8th week.  
Comparator Agent  Standard care   Participants in the control group will be instructed to continue their activities of daily living and maintain standard care given by physician  
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Age between 40-70 years
Individuals diagnosed with T2DM and on medication
SARC-F score more than or equal to 4
Less than 600 MET minutes per week  
 
ExclusionCriteria 
Details  History of lower limb amputation and lower limb injury
Active lower limb ulcer
Neuromuscular pathology
Any Neurodegenerative diseases
Any Cardiac disorders
Patients diagnosed with Cancer
Systemic illness which hinders participation in the study  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
SARC F Questionairre
Hand Grip Strength using Jamar Hand held Hydraulic Dynamometer
Quadriceps and Calf muscle circumference using Inch tape
Skeletal mass index using BIA- Inbody 270 
Baseline
12th week of intervention
24th week  
 
Secondary Outcome  
Outcome  TimePoints 
Muscle ultrasound imaging of Quadriceps and Calf muscles
Blood Biomarkers
Timed Up and Go test  
Baseline
12th week of intervention
24th week  
 
Target Sample Size   Total Sample Size="224"
Sample Size from India="224" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   20/02/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Evaluating the effect of Exercise-based intervention in Type 2 Diabetes mellitus(T2DM) with Sarcopenia on Skeletal mass index, SARC-F, Hand grip strength, Limb girth of Quadriceps and Calf muscle, Physical performance using Timed-up and Go test and few blood biomarkers and ultrasound imaging of quadriceps and calf muscle.
Patients with T2DM and Sarcopenia coming to the Center for Podiatry and Diabetic Foot Care and Research, Department of Physiotherapy, and Department of Endocrinology, Kasturba Hospital Manipal will be thoroughly screened in accordance with the inclusion and exclusion criteria and will be included in the study. Each participant will be informed in detail about the study and the participant information sheet (PIS) along with an informed consent form will be provided to them. If they agree to take part in the study, We will get their written informed permission. 
The participants will be screened for Sarcopenia using the SARC-F questionnaire and Calf Circumference measurement will be done. A GPAQ questionnaire will be used to assess the Physical activity level. 
Demographic details and detailed clinical evaluation of the study participants will be done. 
The baseline primary and secondary outcome measures SARC- F questionnaire, Hand grip strength, Limb girth assessment of Quadriceps and calf muscle, Skeletal mass index, blood biomarkers, ultrasound imaging to observe the soft tissue changes of Quadriceps and calf muscles, and Timed up and go test will be evaluated at the time of the initial visit along with the demographic details of each participant.
Once the patient completes all the baseline assessments, Individuals will be randomized into Interventional and Control groups with a computer-generated varied blocked randomization method. The allocation will be conducted with the sealed envelope method, the sequence will be written in paper which will be put inside an envelope and will be opened by an assistant at the time of each recruitment. 
Exercise-based intervention protocol will be explained to each participant and the first session will be conducted under the supervision of the primary investigator. 
Exercise-based intervention involves Resistance exercise, Aerobic training, and Balance training exercises. Exercises will be for 12 weeks. These exercises will be progressed as per the resistance, and repetition in the 4th and 8th week. Supervised exercise sessions will be planned every two weeks. 
Participants in the control group will be instructed to continue their activities of daily living as usual and also Maintain standard care by the physician. 
All the outcome measures will be assessed at the baseline, the 12th week of treatment, and at the 24th week(Follow-up).
The participant has to visit the hospital 3 times.

 
 
Close